This is a research study for people diagnosed with Leukemia that has returned after being in remission. The purpose of this study is to see if the study medication (LP-118) works better in treating your cancer.
If you decide to take part, you will be given the medication LP-118 that is tablet to be taken once daily. At each visit you will be asked questions about your health and any other medications you're taking. Blood draws for routine tests should be expected at every onsite visit. A study team member will assess the effect of your cancer on how well you perform activities of daily living. you will be asked to complete a pill diary as directed, including recording the date and time when you take the medication. Bone Marrow biopsies are required through out the study at different time points. CT/MRI/PETCT scan are required at least 4 times while participating in the study.
Study Medication, Gas Reimbursement as applicable, meal reimburement as applicable, lodging reimbursement as applicable.
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Joshua Zeidner
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
21-0759